Articles tagged with: Fundraiser
NewsFlash »
D.C. Ride-a-thon – On August 1, Jim Barth, a multiple myeloma patient, will begin his ride on his scooter from Clearwater, FL to the International Myeloma Foundation (IMF) Seminar in Washington, D.C. Jim is looking for sponsors to help raise funds for the IMF and the Tampa – St. Petersburg Multiple Myeloma Education Group. The IMF Seminar will be held on August 7 and 8. For more information, please visit Jim’s Web site. Donations may be made on his page.
5430 Long Course Triathlon – On August 9, the 5430 Long Course Triathlon will begin at 6:30 a.m. and end at 3:30 p.m. The triathlon will be held in Boulder, CO, and the Leukemia & Lymphoma Society’s Team In Training (TNT) will be participating. To join Team In Training for the Triathlon, please visit the TNT Web site.
Ontario Approves Funding For Revlimid – On July 24 the Ontario government approved funding for Revlimid (lenalidomide) to be used with dexamethasone (Decadron) for multiple myeloma patients. This makes Ontario the second Canadian province to fund Revlimid, following British Columbia. Myeloma Canada is now urging other provinces to follow the examples set by the two provinces. For more information, please visit the CNW Group Web site.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
1st Annual Ronnie Marshall Memorial Poker Run For Multiple Myeloma – In an interesting twist on multiple myeloma fundraisers, there will be a poker run on July 25 beginning at CJ’s Backroom in Lusby, MD. A poker run is an organized motorcycle ride in which riders stop at five checkpoints along the designated route. At each checkpoint, the rider draws a card and records the card on a score sheet. At the end of the route the person with the best poker hand is the winner. Registration for this fundraiser will take place from 10 a.m. to noon. The ride fee is $20. For more information, please visit the Let's Ride Web site.
LLS and FORMA Therapeutics Collaborate To Bring New Therapies To Patients Faster – On July 20 The Leukemia & Lymphoma Society (LLS) and FORMA Therapeutics announced their partnership to accelerate LLS research projects focused on therapies for blood cancer patients. Ten small molecule candidates discovered by LLS grant-funded academic researchers are going to be analyzed by FORMA’s advanced technology to find which molecules are best suited for clinical trials. This partnership is the latest in the LLS’s Therapy Acceleration Program that is meant to move potential therapies quickly through the FDA drug approval process. For more information, please see the FORMA Therapeutics press release.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
NCI Discovery May Be Used Toward Cancer Vaccine Development – On June 8 the National Cancer Institute (NCI) announced that it had determined the structure of thin fibers that are commonly found on the surface of a type of E. coli bacteria responsible for traveler’s diarrhea. The researchers, who work in NCI’s Center for Cancer Research, employed atomic resolution technology to determine how the fibers assemble upon exit from the cells through a pore on the bacterial surface. Knowledge of this mechanism is currently being used to develop a vaccine for traveler’s diarrhea, although it may also be used later on for cancer vaccine development and cancer cell motility studies. For more information on the study, please read the NCI press release.
Sail-A-Thon – The Leukemia & Lymphoma Society (LLS) is sponsoring a sailing fundraiser for children and young adults on June 25 at the Fishing Bay Yacht Club in Deltaville, VA. The LLS will collect donations based on the number of laps that participants sail around the course. For more information, please visit the LLS Web site.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.
News»
Returners Host Gaming Marathon To Benefit Multiple Myeloma – On June 5 the Returners will hold a 48-hour video gaming marathon to raise money for the Multiple Myeloma Research Foundation. The Returners are a group of video gamers who organize game marathons to raise funds for charities. For more information, please see the event announcement at the Returners Web site.
CyDex Receives Support For Melphalan Development Program - The Kansas Bioscience Authority (KBA) has awarded CyDex Pharmaceuticals $195,000 to commercialize re-formulated drugs that address limitations of existing therapies. A particular …
NewsFlash »
The Road To Discovery: Emerging Therapies In Blood Cancers — The Leukemia & Lymphoma Society (LLS) will host a free patient education program on April 30 from 5:30 p.m. to 7:30 p.m. at The White Inn in Fredonia, NY. The program will discuss how new drugs are discovered, researched, and approved for treatment; recent and ongoing advances in the treatment of blood cancers; and participation in clinical trials as a possible treatment option. Pre-registration for this event is required on or before April 24. For more information, visit the LLS Web site.
Regatta Cup — The 2009 Leukemia Cup Regatta series, sponsored by the Leukemia & Lymphoma Society (LLS), will hold several fundraisers around the country throughout the month of May. Locations include San Diego; Panama City Beach, FL; Carlyle, MO; Southport, NC; and Lake Mission Viejo, CA. The annual Regatta Cup series has raised more than $27 million since its inception in 1988, with the 2008 events raising more than $3.6 million from 38 Regattas.
ARRY-520 Clinical Trials For Multiple Myeloma — Relapsed/refractory multiple myeloma patients are being recruited for a Phase 1/2 trial involving ARRY-520, a drug that prevents cancer cell reproduction. These Phase 1/2 clinical trials will test for safety and tolerability as well as disease response. For more information about the Phase 1/2 study, visit ClinicalTrials Web site. To learn more about ARRY-520, see the press release by ARRAY BioPharma.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
St. Anthony's Triathlon – The Leukemia and Lymphoma Society (LLS) will host the St. Anthony's Triathlon in St. Petersburg, FL on April 26. During the race, participants will swim through Tampa Bay, bike along waterways and harbors, and run through neighborhoods in the area. For more information, visit the LLS Web site.
49th Annual Scientific Meeting Of The British Society For Haematology – The British Society for Haematology will hold its annual conference from April 27 – 29 in Brighton. The conference will include educational sessions, satellite symposiums, and poster sessions. For more information, visit the British Society of Haematology Web site.
MLN4924 Clinical Trials For Multiple Myeloma – Relapsed/refractory multiple myeloma patients are being recruited for a Phase 1 clinical trial involving MLN4924, a drug that inhibits cancer cell proliferation. These Phase 1 clinical trials will test for safety and tolerability as well as disease response. Phase 2 clinical trials involving MLN4924 are expected to begin within the year to test the effectiveness of the drug. MLN4924 is also being tested as a treatment for lymphoma. For more information about the Phase 1 study, visit ClinicalTrials Web site.
2009 Rush Limbaugh Cure-A-Thon For The LLS – To kickoff his 19th annual Cure-A-Thon, which benefits the Leukemia and Lymphoma Society (LLS), Rush Limbaugh personally donated $300,000 toward the search for a cure for blood cancers. In his April 17 broadcast, Limbaugh mentioned that the total number of donors to the Cure-A-Thon increased 33 percent this year, and he is optimistic about raising a record-breaking amount. He praised the efforts of the LLS in education and research, especially noting the society's efforts in supporting the development of Velcade. To read the transcript from his broadcast, visit the Rush Limbaugh show. Donations for the Cure-A-Thon are still being accepted.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.
NewsFlash »
Cultural Competency At The Bedside: Breaking Down Barriers To Cancer Care – On April 23, the Leukemia & Lymphoma Society (LLS) and the National Cancer Institute will be holding an educational program on cultural competency for nursing professionals and social workers. The program will be held at Baruch College in New York City and runs from 8 a.m. to 1 p.m. Topics to be discussed include cancer occurrence in different ethnic groups, cultural viewpoints and values, financial difficulties, and helping patients find direction in dealing with cancer care. The program is free, but registration is required by April 20. For more information or to register, please visit the LLS Web site.
Dental Health During Cancer Treatments – CancerCare is sponsoring an educational teleconference workshop on April 24 from 1:30 p.m. to 2:30 p.m. ET. Professionals will discuss dental issues and wellness during cancer treatments. Questions are welcomed and encouraged. There are no participation fees or phone charges, although registration is required. For further information or to register, please see the CancerCare Web site.
Miles For Myeloma 5K Walk/Run – The International Myeloma Foundation (IMF) will be hosting a walk/run event on April 25 in Philadelphia. The event begins at 9 a.m. and the course follows Martin Luther King Drive. Proceeds from this event will benefit myeloma research and patients in need of support. For further information or to register, please visit the IMF Web site.
For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.